The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
National Organization of Vascular Anomalies
PO Box 38216
Greensboro, NC 27438-8216
The National Organization of Vascular Anomalies (NOVA) is a non-profit, voluntary organization whose mission is to provide assistance to patients and their families affected by vascular anomalies including hemangioma, vascular malformations, and related syndromes. It also provides resource materials to medical professionals to assist them in management of patient care. Hemangioma is the most common benign tumor of infants and children. Vascular malformations are abnormally developed blood vessels. Established in 1996 and incorporated in 1997, NOVA serves patients and family members, the general public, health professionals, and other professionals such as educators, with programs and activities that include free medical conferences, support groups, patient networking, education, referrals, audio-visual aids, brochures, web site and a newsletter. The organization also assists with insurance claims and coordinates efforts for free transportation to medical appointments. NOVA, formerly Hemangioma Newsline, changed its name in August 2004.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.